Apricot Capital
Overview
Apricot Capital is a venture capital firm founded in 2015 that specializes in incubating and scaling early- and growth-stage companies in the biotech, medtech, and life science sectors within China's healthcare ecosystem.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanjing Zaiming Pharmaceutical Co., Ltd. | Jun 2025 | Series A | Co-investor |
| Evopoint Biosciences | May 2018 | Series A | Co-investor |
| QL Biopharm | Mar 2026 | Series C | Co-investor |
| Bellen Chemistry | Jun 2020 | Series D | Co-investor |
| BCIFlex | Mar 2026 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Apricot Capital based?
Apricot Capital is headquartered in Shanghai, China.
When was Apricot Capital founded?
Apricot Capital was founded in 2015.
How many portfolio companies does Apricot Capital have?
Apricot Capital has 40 portfolio companies in Caplight's dataset.
What are some companies in Apricot Capital's portfolio?
Portfolio companies visible on Caplight include Nanjing Zaiming Pharmaceutical Co., Ltd., Evopoint Biosciences, QL Biopharm, Bellen Chemistry, BCIFlex.
What was Apricot Capital's most recent investment shown here?
Apricot Capital's most recent investment in this portfolio sample was in BCIFlex in 2026.
What sectors does Apricot Capital focus on?
Apricot Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Consumer & Commerce, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Frontier & Industrial Tech.
What company stages does Apricot Capital focus on?
Apricot Capital typically invests at the Early stage.
What is Apricot Capital's AUM?
Apricot Capital's assets under management are estimated between $845.1M and $915.5M.